LESLIE HASS: Open Payments
NPI 1275913824 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 40 payments from 9 companies in 2025. Trend: 2023 $531 · 2024 $445 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $418 |
| ABBVIE INC. | 17 | $210 |
| E.R. Squibb & Sons, L.L.C. | 4 | $162 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Alkermes, Inc. | 2 | $42 |
| Lundbeck LLC | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, COBENFY, FANAPT, REXULTI, Auvelity, ARISTADA, LYBALVI.
Industry payments across ID — which companies pay providers there.
